Active-ingredient Dossier
Normal Immunoglobulin
Active-ingredient Dossier for Normal Immunoglobulin (immunoglobulin replacement therapy). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: KIOVIG
- Brand: FLEBOGAMMA
- Brand: GAMUNEX
- Brand: INTRATECT
- Brand: CUVITRU
- Brand: HYQVIA
- Therapeutic area: Immunology
What is
Normal Immunoglobulin Normal Immunoglobulin is an immunoglobulin replacement therapy.
Australian brands containing
Normal Immunoglobulin — KIOVIG — FLEBOGAMMA — GAMUNEX — INTRATECT — CUVITRU — HIZENTRA — HYQVIA — INTRAGAM — PRIVIGEN
Therapeutic areas
Normal Immunoglobulin is registered across multiple therapeutic areas: Immunology (5 brands), Neurology (2 brands), Haematology (1 brand), and Oncology (1 brand).
Sponsor landscape
Normal Immunoglobulin is marketed by three sponsors: Takeda Pharmaceuticals, Grifols, and CSL Behring.
PBS and regulatory activity
The latest AusPAR for Normal Immunoglobulin was published on 20 July 2021, with four brands having AusPARs on record. No PBAC outcomes are recorded for brands containing this ingredient.